Skip to main content

Table 5 Relationship between AGO scorea and complete resection at secondary cytoreductive surgery

From: Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

 Complete resectionbTotal
No (R1,R2)Yes (R0)
AGO score
 negative13 (59.1%)20 (35.1%)33
 positive9 (40.9%)37 (64.9%)46
Total225779
  1. AGO score assessment had a sensitivity, specificity, positive predictive value, and negative predictive value of 64.9, 59.1, 80.4, and 39.4%, respectively
  2. aAGO score, Arbeitsgemeinschaft Gynäkologische Onkologie score
  3. bThe level of residual disease after SCS was divided into no gross (R0), 1–9 mm (R1), and equal to or more than 10 mm residual disease (R2)